Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report
Clinical, Cosmetic and Investigational Dermatology · 2026-10 · Volume 19 · 1-5
DOI: 10.2147/ccid.s642757 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2026-10. Verfasst von Hui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University People's Hospital, Beijing, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Peking University People's Hospital, Beijing, People's Republic of China.
Zitieren
APA
Wang, H., Mu, Z., Zhong, Y., Wen, G., Zhao, Y., & Li, K. (2026). Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report. Clinical, Cosmetic and Investigational Dermatology, Volume 19, 1-5. https://doi.org/10.2147/ccid.s642757
Vancouver
Wang H, Mu Z, Zhong Y, Wen G, Zhao Y, Li K. Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report. Clinical, Cosmetic and Investigational Dermatology. 2026;Volume 19:1-5. doi:10.2147/ccid.s642757
BibTeX
@article{Wang2026,
author = {Wang, Hui and Mu, Zhanglei and Zhong, Yu and Wen, Guangdong and Zhao, Yan and Li, Kun},
title = {Successful Treatment of Refractory Pemphigus Vulgaris with Ultra-Low-Dose Rituximab in a High-Risk Patient: A Case Report},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2026},
volume = {Volume 19},
pages = {1--5},
doi = {10.2147/ccid.s642757}
}
EUVIMED